Molecular fingerprinting catches responders to therapeutic agents
1 Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, 8 College Road, Singapore 169857, Singapore
2 Infectious Diseases, Genome Institute of Singapore, 60 Biopolis Street, Genome, #02-01, Singapore 138672, Singapore
3 Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, 14 Medical Drive, #12-01, Singapore 117599, Singapore
4 Computational and Mathematical Biology, Genome Institute of Singapore, 60 Biopolis Street, Genome, #02-01, Singapore 138672, Singapore
Genome Biology 2013, 14:135 doi:10.1186/gb-2013-14-10-135
See related Research, http://genomebiology.com/2013/14/10/R110Published: 31 October 2013
High-dimensional -omics profiling predicts responses to therapeutic agents in breast cancer cell lines that can be effectively applied to patient selection in clinical trials.